reorganization

GSK CEO Walmsley is reorganizing R&D, dropping drugs and adding a new focus on cancer research
GSK CEO Walmsley is reorganizing R&D, dropping drugs and adding a new focus on cancer research
Endpoints
GSK
reorganization
Emma Walmsley
Pharma CEOs
R&D
cancer
Flag link:
Takeda relocates hundreds of R&D, vaccine staffers and cuts 480 in sales: report
Takeda relocates hundreds of R&D, vaccine staffers and cuts 480 in sales: report
Fierce Pharma
Takeda
R&D
drug reps
layoffs
reorganization
vaccines
Boston
Flag link:
Shire will cut U.S. locations and move HQ in consolidation push
Shire will cut U.S. locations and move HQ in consolidation push
Fierce Biotech
Shire
reorganization
consolidation
R&D
Flag link:
Shire’s Ornskov dictates another big revamp, with R&D/HQ moving into Cambridge
Shire’s Ornskov dictates another big revamp, with R&D/HQ moving into Cambridge
Endpoints
Shire
Flemming Ornskov
R&D
reorganization
Cambridge
Flag link:
3 Reasons Teva Pharmaceutical Industries Lost Another $520 Million in Market Value in April
3 Reasons Teva Pharmaceutical Industries Lost Another $520 Million in Market Value in April
Fierce Pharma
Teva Pharmaceutical
bribery
Women's Health
oncology
reorganization
Flag link:
Takeda chops into Ariad staff, handing out about 180 pink slips as it revamps Boston ops
Takeda chops into Ariad staff, handing out about 180 pink slips as it revamps Boston ops
Endpoints
Takeda
layoffs
Ariad Pharmaceuticals
reorganization
Flag link:
Novo rejigs U.S. team as passed-over CEO candidate heads for the door
Novo rejigs U.S. team as passed-over CEO candidate heads for the door
Fierce Pharma
Novo Nordisk
reorganization
Flag link:
Lilly shuffles management as new CEO signs on
Lilly shuffles management as new CEO signs on
BioPharma Dive
Eli Lilly
David Ricks
reorganization
Flag link:
Bristol-Myers reshapes operations in wake of Opdivo miss
Bristol-Myers reshapes operations in wake of Opdivo miss
BioPharma Dive
Bristol-Myers Squibb
reorganization
Opdivo
Flag link:
Why Novo Nordisk Stock Fell 10.2% in September
Why Novo Nordisk Stock Fell 10.2% in September
Motley Fool
Novo Nordisk
reorganization
layoffs
Flag link:
Novartis’ ongoing global R&D reorganization claims another group with 85 staffers
Novartis’ ongoing global R&D reorganization claims another group with 85 staffers
Endpoints
Novartis
R&D
layoffs
reorganization
Flag link:
Takeda will transfer 300 staffers to CRO in ongoing R&D overhaul
Takeda will transfer 300 staffers to CRO in ongoing R&D overhaul
Endpoints
Takeda
reorganization
R&D
CROs
Flag link:
Medivir plans year-end split
Medivir plans year-end split
BioPharma Dive
Medivir
R&D
reorganization
Flag link:
Amid layoff fears, AstraZeneca stakes a ‘For Sale’ sign on US campus
Amid layoff fears, AstraZeneca stakes a ‘For Sale’ sign on US campus
Endpoints
AstraZeneca
reorganization
layoffs
Delaware
Flag link:
Allergan to consolidate operations in NJ
Allergan to consolidate operations in NJ
BioPharma Dive
Allergan
New Jersey
reorganization
Flag link:
Pfizer Breakup May Depend on Trump or Clinton Winning the Election
Pfizer Breakup May Depend on Trump or Clinton Winning the Election
Fortune
Pfizer
Donald Trump
Hillary Clinton
2016 Presidential election
reorganization
Flag link:
Pfizer addresses speculation about divorce
Pfizer addresses speculation about divorce
BioPharma Dive
Pfizer
reorganization
Flag link:
To split or not to split? One Wall Street wag thinks Pfizer may remain intact
To split or not to split? One Wall Street wag thinks Pfizer may remain intact
Stat
Pfizer
reorganization
Flag link:
Pfizer's Split: A Double-Edged Sword?
Pfizer's Split: A Double-Edged Sword?
Forbes
Pfizer
reorganization
Flag link:
Novartis splits drugs unit in two, pharma chief to depart
Novartis splits drugs unit in two, pharma chief to depart
BioPharma Dive
Novartis
reorganization
oncology
restructuring
Flag link:

Pages